Evercyte contributing to reduce animal testing at key events

December 7th, 2023, Vienna, Austria

We participated as an invited attendee at the Center for Alternatives to Animal Testing European annual board meeting (CAAT-Europe 2023) and as an invited scientific speaker at the Austrian 3Rdays conference dedicated to Replacement, Reduction and Refinement in animal testing.

Dr. Regina Grillari, our co-founder and COO/CSO, delivered a talk titled ‘Good Cell Culture Practice,’ highlighting the significance of GCCP methodologies in advancing in vitro bioassays and drug screening independent of animal usage. She emphasized the role of Evercyte’s immortalized cells presenting them as viable alternatives to animal testing.

Explore our portfolio featuring immortalized cell lines and our specialized services in cell line development.